Persistent URL of this record https://hdl.handle.net/1887/117782
In Collections
This item can be found in the following collections:
![Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response
- All authors
- Keystone, E.; Heijde, D. van der; Smolen, J.; Weinblatt, M.; Kvien, T.; Strand, V.; Ansari, Z.; Goel, N.; Combe, B.
- Date
- 2010-06-30
- Title of host publication
- Journal of Rheumatology
- Volume
- 37
- Issue
- 6
- Pages
- 1333 - 1333